everolimus
ItalyDrugs containing this active substance
-
It is an anticancer drug used to treat postmenopausal women with advanced breast cancer (when other treatments no longer work), advanced neuroendocrine tumors originating from the stomach, intestine, lung, or pancreas, and advanced renal cell carcinoma.
Form: tablets
Active substance Dosage everolimus - ATC: L01EG02
Manufacturer: NOVARTIS EUROPHARM LIMITED
-
It is used in adults to prevent the immune system from rejecting a transplanted kidney, heart, or liver. It is taken together with other medicines such as cyclosporine, tacrolimus, or corticosteroids.
Form: tablets
Active substance Dosage everolimus - ATC: L04AH02
Manufacturer: NOVARTIS FARMA S.P.A.
-
It is an anticancer drug that reduces the blood supply to the tumor and slows the growth and spread of cancer cells. It is used to treat advanced breast cancer in postmenopausal women, advanced neuroendocrine tumors (stomach, intestine, lung, or pancreas), and advanced kidney cancer.
Form: tablets
Active substance Dosage everolimus - ATC: L01XE10
Manufacturer: biocon pharma malta i limited
-
It is an anticancer drug used to treat postmenopausal women with advanced breast cancer (with positive hormone receptor status) when other treatments are no longer effective. It is taken together with another medicine called exemestane.
Form: tablets
Active substance Dosage everolimus - ATC: L01EG02
Manufacturer: ETHYPHARM
-
It is an anticancer drug used to treat postmenopausal women with advanced breast cancer (when other treatments are no longer effective), advanced neuroendocrine tumors originating from the stomach, intestine, lung, or pancreas, and advanced kidney cancer.
Form: tablets
Active substance Dosage everolimus - ATC: L01EG02
Manufacturer: MEDAC PHARMA SRL
-
It is an anticancer medicinal product used to treat postmenopausal women with advanced breast cancer (when other treatments are no longer effective), advanced neuroendocrine tumors originating in the stomach, intestine, lung, or pancreas, and advanced renal cell carcinoma.
Form: tablets
Active substance Dosage everolimus - ATC: L01EG02
Manufacturer: SANDOZ GMBH
-
This medicinal product contains everolimus, a substance authorized for the treatment of certain medical conditions.
Form: tablets
Active substance Dosage everolimus - ATC: L01EG02
Manufacturer: TAMARANG S.A.
-
Votubia is an anticancer medicinal product used to reduce the size of certain tumors (renal angiomyolipomas and subependymal giant cell astrocytomas) caused by tuberous sclerosis. The dispersible tablet versions are also used for the treatment of focal seizures associated with tuberous sclerosis in adults and children.
Form: tablets
Active substance Dosage everolimus - ATC: L01EG02
Manufacturer: NOVARTIS EUROPHARM LIMITED